Gloria Cheng, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Gloria Cheng’s office at (415) 600-1020 to ask if they take your plan before you enroll.
California Medical Board record
Licence G51816 · Cancelled
Licence status: Cancelled · since 1984 · University of California, Irvine College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$25,574
Medicare paid this office $25,574 for 66 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 42 | $6,262 | $85 |
| Long return visit (40+ min) | 22 | $4,499 | $136 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $3,309 | $132 |
| Sarscov2 vac 50 mcg/0.5ml im | 14 | $2,141 | $153 |
| Short return visit (20+ min) | 16 | $1,705 | $68 |
See all 9 services
| Return visit (30+ min) | 42 | $6,262 | $85 |
| Long return visit (40+ min) | 22 | $4,499 | $136 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $3,309 | $132 |
| Sarscov2 vac 50 mcg/0.5ml im | 14 | $2,141 | $153 |
| Short return visit (20+ min) | 16 | $1,705 | $68 |
| Influenza vaccine, inactivated | 17 | $1,391 | $82 |
| Administration of influenza virus vaccine | 18 | $735 | $39 |
| Admn sarscov2 vacc 1 dose | 14 | $722 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 13 | $188 | $13 |
Who their Medicare patients are
66 Original Medicare patients in 2024. Average age 75 · Women 59% · Also on Medicaid 20% · Health risk score 1.11. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 73% · Diabetes 26% · Chronic kidney disease 26% · Coronary heart disease 23% · Depression 21% · Cancer 18%.
The office billed $79,621, Medicare allowed $32,175 and paid $25,574; for 419 services of 27 kinds; $5,518 of it was for drugs given in the office and $20,056 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 66 | 419 | 75 | 1.11 | $79,621 | $25,574 |
| 2023 | 103 | 526 | 75 | 0.99 | $89,835 | $27,836 |
| 2022 | 358 | 835 | 76 | 1.03 | $148,204 | $54,950 |
| 2021 | 551 | 879 | 74 | 0.87 | $128,328 | $38,980 |
| 2020 | 208 | 276 | 73 | 0.96 | $38,237 | $12,002 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 47 | $7,498 | $79 |
| Long return visit (40+ min) | 26 | $4,194 | $120 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,124 | $133 |
| Short return visit (20+ min) | 27 | $2,195 | $61 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 13 | $986 | $76 |
| Adm sarscv2 bvl 50mcg/.5ml a | 19 | $807 | $42 |
| Administration of influenza virus vaccine | 13 | $411 | $32 |
| Administration of pneumococcal vaccine | 12 | $379 | $32 |
2022: 11 services
| Return visit (30+ min) | 87 | $14,667 | $95 |
| Adm sarscv2 bvl 50mcg/.5ml a | 173 | $7,133 | $41 |
| Long return visit (40+ min) | 37 | $6,782 | $128 |
| Short return visit (20+ min) | 49 | $4,553 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $2,919 | $133 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 62 | $2,609 | $42 |
| Influenza vaccine split virus, preservative free | 31 | $2,121 | $68 |
| Administration of influenza virus vaccine | 54 | $1,679 | $31 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 22 | $1,546 | $70 |
| Short return visit | 15 | $688 | $34 |
| Administration of pneumococcal vaccine | 21 | $662 | $32 |
2021: 10 services
| Short return visit (20+ min) | 124 | $10,460 | $63 |
| Return visit (30+ min) | 69 | $8,058 | $97 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 324 | $5,570 | $16 |
| Long return visit (40+ min) | 17 | $2,441 | $144 |
| Influenza vaccine split virus, preservative free | 23 | $1,562 | $65 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 37 | $1,547 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 78 | $873 | $11 |
| New patient visit (30+ min) | 13 | $785 | $60 |
| Administration of influenza virus vaccine | 24 | $453 | $18 |
| Administration of pneumococcal vaccine | 12 | $222 | $18 |
2020: 4 services
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 135 | $3,368 | $25 |
| Short return visit (20+ min) | 43 | $3,238 | $61 |
| Return visit (30+ min) | 13 | $1,232 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $170 | $13 |
Drugs they prescribed that Part D paid
$163,550
Pharmacies billed $163,550 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (51 of 1,325) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%. Long-acting opioids: 22% of their opioid prescriptions.
1,135 generic and fewer than 11 brand-name prescriptions · $163,550 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 30 | $42,887 | $1,430 |
| Vascepa | 13 | $10,099 | $777 |
| Oxycontin | 11 | $6,455 | $587 |
| Dexlansoprazole Dr | 11 | $2,524 | $229 |
| Valacyclovir | 15 | $1,239 | $83 |
See all 36 drugs
| Mounjaro | 30 | $42,887 | $1,430 |
| Vascepa | 13 | $10,099 | $777 |
| Oxycontin | 11 | $6,455 | $587 |
| Dexlansoprazole Dr | 11 | $2,524 | $229 |
| Valacyclovir | 15 | $1,239 | $83 |
| Atorvastatin | 94 | $1,095 | $12 |
| Duloxetine | 29 | $904 | $31 |
| Pantoprazole | 40 | $882 | $22 |
| Acetaminophen-Codeine | 14 | $864 | $62 |
| Rosuvastatin | 41 | $835 | $20 |
| Levothyroxine | 55 | $828 | $15 |
| Gabapentin | 31 | $664 | $21 |
| Amlodipine Besylate | 75 | $655 | $9 |
| Valsartan | 16 | $598 | $37 |
| Lisinopril | 66 | $569 | $9 |
| Synthroid | 12 | $563 | $47 |
| Metoprolol | 28 | $515 | $18 |
| Losartan-Hydrochlorothiazide | 12 | $476 | $40 |
| Tamsulosin | 28 | $448 | $16 |
| Alendronate | 37 | $428 | $12 |
| Omeprazole | 30 | $423 | $14 |
| Losartan | 41 | $416 | $10 |
| Hydrocodone-Acetaminophen | 25 | $378 | $15 |
| Buspirone | 16 | $333 | $21 |
| Donepezil | 17 | $316 | $19 |
| Ezetimibe | 14 | $296 | $21 |
| Simvastatin | 23 | $258 | $11 |
| Sertraline | 22 | $251 | $11 |
| Metformin | 18 | $249 | $14 |
| Famotidine | 16 | $205 | $13 |
| Lansoprazole | 16 | $184 | $12 |
| Zolpidem | 20 | $143 | $7 |
| Lovastatin | 13 | $110 | $8 |
| Fluticasone Propionate | 16 | $85 | $5 |
| Lorazepam | 14 | $57 | $4 |
| Ondansetron | 14 | $24 | $2 |
Year by year
| 2024 | 1,325 | 124 | 4% (51) | None | $163,550 |
| 2023 | 1,437 | 149 | 4% (52) | None | $169,022 |
| 2022 | 1,529 | 214 | 5% (74) | None | $188,862 |
| 2021 | 1,105 | 186 | 4% (47) | None | $122,984 |
| 2020 | 1,335 | 237 | 3% (41) | None | $155,102 |
| 2019 | 1,275 | 259 | 3% (40) | None | $163,303 |
| 2018 | 1,609 | 299 | 8% (130) | 22% | $221,154 |
| 2017 | 1,784 | 243 | 11% (195) | 21% | $220,977 |
| 2016 | 1,497 | 223 | 11% (160) | None | $128,261 |
| 2015 | 974 | 207 | 14% (134) | None | $65,863 |
| 2014 | 105 | 65 | 17% (18) | 14% | $4,229 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Trulicity | 14 | $19,581 | $1,399 |
| Jardiance | 12 | $14,954 | $1,246 |
| Mounjaro | 12 | $14,825 | $1,235 |
| Tresiba Flextouch U-100 | 13 | $8,575 | $660 |
| Oxycontin | 13 | $6,973 | $536 |
| Linzess | 12 | $6,484 | $540 |
| Atorvastatin | 137 | $1,991 | $15 |
| Valacyclovir | 17 | $1,457 | $86 |
| Ezetimibe | 22 | $1,062 | $48 |
| Levothyroxine | 55 | $1,022 | $19 |
| Amlodipine Besylate | 89 | $1,022 | $11 |
| Duloxetine | 31 | $970 | $31 |
| Gabapentin | 40 | $876 | $22 |
| Acetaminophen-Codeine | 12 | $875 | $73 |
| Omeprazole | 35 | $770 | $22 |
| Losartan-Hydrochlorothiazide | 14 | $695 | $50 |
| Lansoprazole | 22 | $689 | $31 |
| Rosuvastatin | 29 | $687 | $24 |
| Losartan | 40 | $613 | $15 |
| Alendronate | 40 | $542 | $14 |
| Sertraline | 38 | $487 | $13 |
| Lisinopril | 64 | $485 | $8 |
| Tamsulosin | 14 | $439 | $31 |
| Pantoprazole | 20 | $386 | $19 |
| Venlafaxine Hcl Er | 19 | $385 | $20 |
| Hydrocodone-Acetaminophen | 16 | $344 | $21 |
| Escitalopram | 13 | $280 | $22 |
| Oxycodone-Acetaminophen | 11 | $262 | $24 |
| Famotidine | 17 | $262 | $15 |
| Metoprolol | 23 | $240 | $10 |
| Metformin | 14 | $232 | $17 |
| Potassium Chloride | 14 | $220 | $16 |
| Donepezil | 15 | $206 | $14 |
| Simvastatin | 14 | $192 | $14 |
| Metoclopramide | 11 | $150 | $14 |
| Ondansetron | 16 | $145 | $9 |
| Zolpidem | 19 | $136 | $7 |
| Trazodone | 12 | $126 | $10 |
| Lamotrigine | 12 | $86 | $7 |
| Lorazepam | 12 | $71 | $6 |
| Hydrochlorothiazide | 11 | $45 | $4 |
2022: 44 drugs
| Trulicity | 15 | $19,839 | $1,323 |
| Eliquis | 22 | $18,964 | $862 |
| Jardiance | 16 | $15,869 | $992 |
| Tresiba Flextouch U-100 | 16 | $6,510 | $407 |
| Oxycontin | 12 | $6,413 | $534 |
| Linzess | 12 | $6,152 | $513 |
| Fluticasone-Salmeterol | 13 | $3,635 | $280 |
| Ramelteon | 11 | $2,869 | $261 |
| Desvenlafaxine Succinate Er | 17 | $2,437 | $143 |
| Atorvastatin | 122 | $1,688 | $14 |
| Venlafaxine Hcl Er | 19 | $1,360 | $72 |
| Rosuvastatin | 35 | $1,154 | $33 |
| Levothyroxine | 47 | $1,109 | $24 |
| Losartan | 68 | $1,033 | $15 |
| Losartan-Hydrochlorothiazide | 11 | $939 | $85 |
| Gabapentin | 50 | $919 | $18 |
| Valacyclovir | 14 | $893 | $64 |
| Metoprolol | 18 | $870 | $48 |
| Acetaminophen-Codeine | 13 | $823 | $63 |
| Duloxetine | 21 | $803 | $38 |
| Amlodipine Besylate | 80 | $766 | $10 |
| Lansoprazole | 13 | $701 | $54 |
| Ezetimibe | 16 | $574 | $36 |
| Oxycodone-Acetaminophen | 29 | $563 | $19 |
| Omeprazole | 33 | $537 | $16 |
| Glipizide Er | 15 | $521 | $35 |
| Trazodone | 20 | $456 | $23 |
| Sertraline | 37 | $452 | $12 |
| Lisinopril | 63 | $433 | $7 |
| Alendronate | 23 | $430 | $19 |
| Tamsulosin | 13 | $374 | $29 |
| Metformin | 22 | $352 | $16 |
| Pantoprazole | 17 | $264 | $16 |
| Hydrocodone-Acetaminophen | 18 | $257 | $14 |
| Famotidine | 23 | $250 | $11 |
| Donepezil | 13 | $188 | $14 |
| Triamterene-Hydrochlorothiazid | 11 | $187 | $17 |
| Metoprolol | 12 | $159 | $13 |
| Metoclopramide | 12 | $158 | $13 |
| Lorazepam | 16 | $145 | $9 |
| Hydrochlorothiazide | 26 | $135 | $5 |
| Zolpidem | 16 | $133 | $8 |
| Lamotrigine | 12 | $93 | $8 |
| Pravastatin | 12 | $85 | $7 |
2021: 25 drugs
| Trulicity | 13 | $11,700 | $900 |
| Tresiba Flextouch U-100 | 19 | $4,129 | $217 |
| Venlafaxine Hcl Er | 13 | $3,707 | $285 |
| Desvenlafaxine Succinate Er | 14 | $1,961 | $140 |
| Fluticasone-Salmeterol | 11 | $1,946 | $177 |
| Atorvastatin | 90 | $1,160 | $13 |
| Losartan | 54 | $1,106 | $20 |
| Ezetimibe | 19 | $985 | $52 |
| Rosuvastatin | 28 | $933 | $33 |
| Acetaminophen-Codeine | 12 | $903 | $75 |
| Valacyclovir | 13 | $837 | $64 |
| Levothyroxine | 29 | $739 | $25 |
| Sertraline | 36 | $640 | $18 |
| Gabapentin | 29 | $611 | $21 |
| Omeprazole | 39 | $573 | $15 |
| Amlodipine Besylate | 55 | $469 | $9 |
| Hydrocodone-Acetaminophen | 15 | $345 | $23 |
| Lisinopril | 51 | $291 | $6 |
| Metformin | 22 | $242 | $11 |
| Tamsulosin | 17 | $210 | $12 |
| Trazodone | 15 | $186 | $12 |
| Alendronate | 11 | $142 | $13 |
| Zolpidem | 14 | $109 | $8 |
| Hydrochlorothiazide | 20 | $85 | $4 |
| Lorazepam | 13 | $31 | $2 |
2020: 36 drugs
| Trulicity | 13 | $10,941 | $842 |
| Eliquis | 14 | $9,771 | $698 |
| Dexilant | 17 | $6,585 | $387 |
| Tresiba Flextouch U-100 | 16 | $3,483 | $218 |
| Rosuvastatin | 33 | $2,138 | $65 |
| Atorvastatin | 101 | $1,627 | $16 |
| Albuterol Sulfate Hfa | 30 | $1,338 | $45 |
| Losartan | 69 | $1,268 | $18 |
| Ezetimibe | 14 | $1,150 | $82 |
| Levothyroxine | 41 | $808 | $20 |
| Rabeprazole | 14 | $775 | $55 |
| Metoprolol | 16 | $480 | $30 |
| Amlodipine Besylate | 51 | $448 | $9 |
| Omeprazole | 34 | $440 | $13 |
| Gabapentin | 24 | $435 | $18 |
| Acetaminophen-Codeine | 12 | $412 | $34 |
| Lisinopril | 53 | $367 | $7 |
| Pioglitazone | 17 | $344 | $20 |
| Diclofenac | 21 | $334 | $16 |
| Sertraline | 37 | $307 | $8 |
| Pantoprazole | 15 | $298 | $20 |
| Clopidogrel | 13 | $287 | $22 |
| Bupropion | 13 | $278 | $21 |
| Potassium Chloride | 12 | $277 | $23 |
| Tamsulosin | 17 | $252 | $15 |
| Metformin | 29 | $227 | $8 |
| Lovastatin | 17 | $197 | $12 |
| Triamterene-Hydrochlorothiazid | 13 | $191 | $15 |
| Simvastatin | 13 | $174 | $13 |
| Hydrochlorothiazide | 29 | $161 | $6 |
| Finasteride | 12 | $134 | $11 |
| Letrozole | 11 | $131 | $12 |
| Trazodone | 13 | $130 | $10 |
| Furosemide | 15 | $118 | $8 |
| Naproxen | 13 | $115 | $9 |
| Lorazepam | 15 | $28 | $2 |
2019: 35 drugs
| Trulicity | 14 | $11,177 | $798 |
| Eliquis | 11 | $6,920 | $629 |
| Uloric | 14 | $5,983 | $427 |
| Dexilant | 13 | $3,604 | $277 |
| Tresiba Flextouch U-100 | 11 | $2,687 | $244 |
| Rosuvastatin | 40 | $2,325 | $58 |
| Acetaminophen-Codeine | 12 | $1,565 | $130 |
| Ezetimibe | 17 | $1,392 | $82 |
| Atorvastatin | 56 | $1,370 | $24 |
| Levothyroxine | 50 | $1,084 | $22 |
| Losartan | 54 | $864 | $16 |
| Proair Hfa | 12 | $832 | $69 |
| Rabeprazole | 14 | $618 | $44 |
| Pantoprazole | 22 | $542 | $25 |
| Gabapentin | 23 | $445 | $19 |
| Montelukast | 15 | $392 | $26 |
| Tamsulosin | 17 | $385 | $23 |
| Metoprolol | 16 | $333 | $21 |
| Letrozole | 12 | $308 | $26 |
| Pravastatin | 11 | $293 | $27 |
| Sertraline | 22 | $293 | $13 |
| Omeprazole | 32 | $274 | $9 |
| Amlodipine Besylate | 54 | $265 | $5 |
| Losartan-Hydrochlorothiazide | 13 | $263 | $20 |
| Potassium Chloride | 11 | $233 | $21 |
| Fluticasone Propionate | 11 | $216 | $20 |
| Lisinopril | 40 | $206 | $5 |
| Metformin | 21 | $169 | $8 |
| Trazodone | 16 | $159 | $10 |
| Simvastatin | 15 | $121 | $8 |
| Zolpidem | 13 | $113 | $9 |
| Furosemide | 16 | $109 | $7 |
| Lovastatin | 11 | $99 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $97 | $9 |
| Hydrochlorothiazide | 25 | $95 | $4 |
2018: 44 drugs
| Forteo | 11 | $37,086 | $3,371 |
| Trulicity | 31 | $23,591 | $761 |
| Jardiance | 30 | $20,326 | $678 |
| Uloric | 20 | $10,552 | $528 |
| Trintellix | 13 | $5,323 | $409 |
| Synjardy | 11 | $5,201 | $473 |
| Dexilant | 12 | $3,322 | $277 |
| Ziprasidone | 13 | $2,685 | $207 |
| Ezetimibe | 14 | $2,475 | $177 |
| Atorvastatin | 85 | $1,982 | $23 |
| Acetaminophen-Codeine | 15 | $1,515 | $101 |
| Levothyroxine | 75 | $1,413 | $19 |
| Rosuvastatin | 25 | $1,358 | $54 |
| Hydrocodone-Acetaminophen | 47 | $1,252 | $27 |
| Metoprolol | 31 | $945 | $30 |
| Losartan | 68 | $707 | $10 |
| Oxycodone | 44 | $593 | $13 |
| Clonazepam | 14 | $516 | $37 |
| Diclofenac | 17 | $463 | $27 |
| Gabapentin | 25 | $413 | $17 |
| Potassium Chloride | 21 | $400 | $19 |
| Metformin | 56 | $353 | $6 |
| Doxycycline Hyclate | 12 | $343 | $29 |
| Escitalopram | 12 | $316 | $26 |
| Losartan-Hydrochlorothiazide | 15 | $290 | $19 |
| Sertraline | 20 | $269 | $13 |
| Amlodipine Besylate | 77 | $269 | $3 |
| Pioglitazone | 13 | $266 | $20 |
| Nitrofurantoin Mono-Macro | 11 | $250 | $23 |
| Lisinopril | 31 | $248 | $8 |
| Pantoprazole | 14 | $207 | $15 |
| Temazepam | 13 | $193 | $15 |
| Alendronate | 18 | $158 | $9 |
| Azithromycin | 25 | $154 | $6 |
| Ultra-Fine Mini Pen Needle | 11 | $139 | $13 |
| Amoxicillin-Clavulanate Potass | 17 | $135 | $8 |
| Hydrochlorothiazide | 27 | $120 | $4 |
| Benazepril | 17 | $104 | $6 |
| Trihexyphenidyl | 12 | $102 | $9 |
| Clonidine | 11 | $89 | $8 |
| Montelukast | 11 | $89 | $8 |
| Metoprolol | 19 | $70 | $4 |
| Atenolol | 13 | $68 | $5 |
| Ciprofloxacin | 13 | $37 | $3 |
2017: 50 drugs
| Forteo | 11 | $33,217 | $3,020 |
| Jardiance | 41 | $22,166 | $541 |
| Trulicity | 27 | $17,961 | $665 |
| Dexilant | 31 | $12,552 | $405 |
| Ezetimibe | 28 | $8,218 | $293 |
| Amitiza | 22 | $7,907 | $359 |
| Trintellix | 17 | $6,002 | $353 |
| Symbicort | 14 | $5,196 | $371 |
| Hydrocodone-Acetaminophen | 92 | $1,943 | $21 |
| Potassium Chloride | 26 | $1,456 | $56 |
| Atorvastatin | 74 | $1,398 | $19 |
| Ziprasidone | 11 | $1,328 | $121 |
| Buspirone | 35 | $1,305 | $37 |
| Levothyroxine | 47 | $1,077 | $23 |
| Acetaminophen-Codeine | 12 | $953 | $79 |
| Oxycodone-Acetaminophen | 20 | $917 | $46 |
| Valacyclovir | 14 | $756 | $54 |
| Rosuvastatin | 21 | $753 | $36 |
| Valsartan | 11 | $736 | $67 |
| Morphine Sulfate Er | 13 | $698 | $54 |
| Losartan | 90 | $657 | $7 |
| Nifedipine Er | 12 | $602 | $50 |
| Oxycodone | 33 | $514 | $16 |
| Metformin | 80 | $488 | $6 |
| Diclofenac | 14 | $477 | $34 |
| Metoprolol | 16 | $374 | $23 |
| Pantoprazole | 20 | $328 | $16 |
| Nitrofurantoin Mono-Macro | 17 | $315 | $19 |
| Clonazepam | 30 | $299 | $10 |
| Amlodipine Besylate | 56 | $269 | $5 |
| Lisinopril | 37 | $257 | $7 |
| Doxycycline Hyclate | 11 | $245 | $22 |
| Alendronate | 27 | $231 | $9 |
| Fluticasone Propionate | 14 | $226 | $16 |
| Amoxicillin-Clavulanate Potass | 20 | $224 | $11 |
| Gabapentin | 18 | $207 | $11 |
| Ciprofloxacin | 35 | $200 | $6 |
| Tramadol | 20 | $179 | $9 |
| Furosemide | 28 | $174 | $6 |
| Omeprazole | 13 | $173 | $13 |
| Mirtazapine | 17 | $170 | $10 |
| Azithromycin | 25 | $159 | $6 |
| Sertraline | 18 | $152 | $8 |
| Hydrochlorothiazide | 19 | $84 | $4 |
| Temazepam | 11 | $81 | $7 |
| Diazepam | 25 | $62 | $2 |
| Triamcinolone Acetonide | 13 | $56 | $4 |
| Clonidine | 13 | $50 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $33 | $3 |
| Metoprolol | 13 | $33 | $3 |
2016: 42 drugs
| Zetia | 18 | $10,095 | $561 |
| Januvia | 17 | $7,765 | $457 |
| Dexilant | 23 | $7,101 | $309 |
| Uloric | 11 | $3,420 | $311 |
| Hydrocodone-Acetaminophen | 85 | $3,376 | $40 |
| Morphine Sulfate Er | 17 | $1,655 | $97 |
| Valsartan | 17 | $1,595 | $94 |
| Ziprasidone | 12 | $1,394 | $116 |
| Levothyroxine | 40 | $1,166 | $29 |
| Atorvastatin | 59 | $1,061 | $18 |
| Acetaminophen-Codeine | 14 | $1,039 | $74 |
| Metoprolol | 18 | $823 | $46 |
| Losartan | 82 | $563 | $7 |
| Bupropion | 12 | $492 | $41 |
| Buspirone | 12 | $485 | $40 |
| Metformin | 63 | $405 | $6 |
| Zolpidem | 21 | $360 | $17 |
| Amlodipine Besylate | 52 | $355 | $7 |
| Nitrofurantoin Mono-Macro | 13 | $344 | $26 |
| Clonazepam | 32 | $313 | $10 |
| Meclizine | 11 | $272 | $25 |
| Amoxicillin-Clavulanate Potass | 19 | $257 | $14 |
| Lisinopril | 29 | $240 | $8 |
| Oxycodone | 12 | $233 | $19 |
| Escitalopram | 16 | $224 | $14 |
| Pioglitazone | 11 | $190 | $17 |
| Gabapentin | 18 | $171 | $9 |
| Diazepam | 28 | $166 | $6 |
| Azithromycin | 19 | $164 | $9 |
| Hydrochlorothiazide | 29 | $151 | $5 |
| Alendronate | 18 | $142 | $8 |
| Temazepam | 16 | $134 | $8 |
| Tramadol | 18 | $133 | $7 |
| Furosemide | 28 | $132 | $5 |
| Sertraline | 13 | $120 | $9 |
| Losartan-Hydrochlorothiazide | 14 | $107 | $8 |
| Clopidogrel | 16 | $104 | $6 |
| Ciprofloxacin | 19 | $90 | $5 |
| Trihexyphenidyl | 11 | $73 | $7 |
| Simvastatin | 12 | $67 | $6 |
| Metolazone | 11 | $66 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $47 | $4 |
2015: 25 drugs
| Januvia | 14 | $5,405 | $386 |
| Dexilant | 12 | $3,521 | $293 |
| Hydrocodone-Acetaminophen | 64 | $2,442 | $38 |
| Morphine Sulfate Er | 17 | $1,600 | $94 |
| Fenofibrate | 14 | $715 | $51 |
| Proair Hfa | 12 | $623 | $52 |
| Levothyroxine | 26 | $576 | $22 |
| Atorvastatin | 46 | $506 | $11 |
| Oxycodone-Acetaminophen | 13 | $373 | $29 |
| Losartan | 35 | $366 | $10 |
| Metformin | 56 | $318 | $6 |
| Pioglitazone | 18 | $297 | $16 |
| Zolpidem | 15 | $280 | $19 |
| Temazepam | 12 | $214 | $18 |
| Clonazepam | 21 | $190 | $9 |
| Alendronate | 14 | $175 | $12 |
| Amlodipine Besylate | 23 | $168 | $7 |
| Azithromycin | 17 | $159 | $9 |
| Amoxicillin-Clavulanate Potass | 16 | $149 | $9 |
| Trazodone | 15 | $123 | $8 |
| Ciprofloxacin | 25 | $114 | $5 |
| Simvastatin | 13 | $113 | $9 |
| Hydrochlorothiazide | 18 | $79 | $4 |
| Diazepam | 11 | $74 | $7 |
| Furosemide | 12 | $27 | $2 |
Money from drug and device companies
$1,228 in 2025
| 2025 | 8 | 10 | None | $1,228 |
| 2024 | 7 | 9 | None | $670 |
| 2023 | 10 | 10 | None | $1,180 |
| 2022 | 4 | 5 | None | $542 |
| 2021 | 1 | 1 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | Nemluvio | $272 | 2 payments
|
| Lilly USA | Zepbound | $245 | 2 payments
|
| Organon | Vtama | $168 | 1 payment
|
| LEO Pharma | Adbry | $137 | 1 payment
|
| Teva Pharmaceuticals USA | None | $132 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $130 | 1 payment
|
See all 10 published payments
| Galderma Laboratories L.P. | Meals · 2025-12-09 | Nemluvio | $147 |
| Madrigal Pharmaceuticals | Meals · 2025-11-20 | Rezdiffra | $130 |
| Gilead Sciences | Meals · 2025-07-22 | Yeztugo | $118 |
| Lilly USA | Meals · 2025-07-17 | Zepbound | $123 |
| LEO Pharma | Meals · 2025-05-20 | Adbry | $137 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | None | $132 |
| Organon | Meals · 2025-03-25 | Vtama | $168 |
| Galderma Laboratories L.P. | Meals · 2025-02-11 | Nemluvio | $125 |
| Lilly USA | Meals · 2025-02-06 | Omvoh | $122 |
| Dexcom | Meals · 2025-01-09 | Dexcom G6 Transmitter | $26 |
See earlier years (2024, 2023, 2022, 2021)
2024: $670
| Dexcom | Dexcom G7 Gss (161) | $173 | 3 payments
|
| Genzyme | Fabrazyme | $144 | 1 payment
|
| Abbvie | None | $137 | 1 payment
|
| Vertex Pharmaceuticals | None | $104 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $63 | 1 payment
|
| Biogen | None | $26 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $23 | 1 payment
|
2023: $1,180
| Dermavant Sciences | Vtama | $195 | 1 payment
|
| Medtronic | Onyx Frontier | $177 | 1 payment
|
| Dexcom | Dexcom G7 Gss (161) | $151 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $131 | 1 payment
|
| Lilly USA | Mounjaro | $120 | 1 payment
|
| Amylyx Pharmaceuticals | Relyvrio | $114 | 1 payment
|
| Gilead Sciences | Epclusa | $108 | 1 payment
|
| Eisai | None | $106 | 1 payment
|
| Myriad Genetic Laboratories | Precisetumor | $43 | 1 payment
|
| Genzyme | Fabrazyme | $35 | 1 payment
|
2022: $542
| Abbvie | Skyrizi | $247 | 2 payments
|
| Lilly USA | Taltz | $118 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $96 | 1 payment
|
| Biogen | None | $82 | 1 payment
|
2021: $119
| GlaxoSmithKline | Zejula | $119 | 1 payment
|
Professional record
- NPI
- 1548662109
- Licence
- CA 51816California G51816: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 3838 California St, Suite 801, San Francisco, CA, 94118
- NPI first listed
- 2014-09-25
- NPI last updated
- 2014-09-25
This is when the NPI record was last certified, not a medical board exam.